Skandinaviska Enskilda Banken (SEB)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-52,000	Closed	-$2.5M	–	1113
2020 Q1	$2.5M	Buy	+52,000	New	+$2.42M	0.03%	422

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s RARX Position: Q2 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 52,000 shares — an estimated $2.5M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $2.5M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Skandinaviska Enskilda Banken (SEB) reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 52,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2.5M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Skandinaviska Enskilda Banken (SEB)'s Ra Pharmaceuticals, Inc. Common Stock position peaked at $2.5M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2020, filed 13 Aug 2020.